Genentech forecast disappoints (Reuters)

[riky]

Genentech forecast disappoints
    (Reuters)

 

Reuters - Genentech Inc  on Thursday reported sales of its most closely watched drug, Avastin, that came in shy of expectations and disappointed investors with its 2009 earnings forecast, sending its shares lower.


You are not allowed to view links. Register or Login/news.yahoo.com/s/nm/20090115/bs_nm/us_genentech